MCK
May 8, 2025 - AI Summary
Undervalued by 29.2% based on the discounted cash flow analysis.
Market cap | $86.91 Billion |
---|---|
Enterprise Value | $93.11 Billion |
Dividend Yield | $2.75 (0.396562166527269%) |
Earnings per Share | $22.54 |
Beta | 0.52 |
Outstanding Shares | 126,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 30.92 |
---|---|
PEG | 56.25 |
Price to Sales | 0.26 |
Price to Book Ratio | 15.99 |
Enterprise Value to Revenue | 0.28 |
Enterprise Value to EBIT | 27.23 |
Enterprise Value to Net Income | 28 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | 1.33 |
No data
No data
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...